AUG 27, 2019 12:44 PM PDT

A Skin Patch Might be the Most Effective Melanoma Treatment

WRITTEN BY: Tiffany Dazet

Researchers from the Massachusetts Institute of Technology (MIT) have developed a fast-acting skin patch that effectively delivers cancer-fighting medication to affected melanoma cells. Their research was presented yesterday at the American Chemical Society (ACS) Fall 2019 Meeting and Exposition. The entire presentation is in the video below.

A skin patch is ideal for melanoma treatment because traditional treatments are not fully effective or convenient. Medicated ointments don’t penetrate skin layers deeply enough, and although syringes deliver medicine efficiently, they’re painful and inconvenient for patient-use.

Microneedle patches are a painless and successful way to deliver treatment. They’re prepared with a layer-by-layer (LbL) coating methods, which covers surfaces with molecules of alternative positive and negative charges. Previous LbL methods created a very sticky film, causing the medication delivery time to last 15 to 90 minutes. Researchers feared that this long application time would lead to non-compliance by patients.

The team from MIT, led by Paula T. Hammond, Ph.D. and her graduate students Yanpu He and Celestine Hong, solved the problem of the prior microneedle patches by designing a new pH-responsive polymer. When tested in mice, this microneedle treatment produced nine times the antibody level compared to intramuscular injections and 160 times the antibody level compared to subcutaneous injections. They saw similar results when testing surgical samples of human skin.

In a statement from ACS, Yanpu He stated: “Our patch has a unique chemical coating and mode of action that allows it to be applied and removed from the skin in just a minute while still delivering a therapeutic dose of drugs. Our patches elicit a robust antibody response in living mice and show promise in eliciting a strong immune response in human skin.”

Hammond and her team are excited for the patch’s use by oncologists to fight melanoma, in addition to its use in fighting infectious diseases. Hammond told ACS reporters that, “We are using low-cost chemistry and a simple fabrication scheme to transform vaccination. Ultimately, we want to get a device approved and on the market.”

Sources: ACS, ACS Nano

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
DEC 28, 2020
Neuroscience
Prenatal Metal Exposure Has Long Term Health Consequences
DEC 28, 2020
Prenatal Metal Exposure Has Long Term Health Consequences
Researchers from Rutgers University have found that prenatal exposure to metals, including lead, arsenic, cobalt, and ni ...
JAN 09, 2021
Drug Discovery & Development
Anticoagulant Drugs Prevent Cancer Spreading to Brain
JAN 09, 2021
Anticoagulant Drugs Prevent Cancer Spreading to Brain
Researchers from the Heidelberg University in Germany have found that anticoagulant drugs that inhibit thrombin (an enzy ...
JAN 14, 2021
Clinical & Molecular DX
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
JAN 14, 2021
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
  Only 10 percent of icebergs are visible on the surface of the water; the remaining 90 percent remains submerged. ...
JAN 18, 2021
Cell & Molecular Biology
MicroRNAs May be Treatment Targets for Traumatic Brain Injury
JAN 18, 2021
MicroRNAs May be Treatment Targets for Traumatic Brain Injury
Traumatic brain injury, which can happen after a blow to the head, has been called a silent epidemic and is the number o ...
JAN 25, 2021
Cardiology
Obesity's Poor Health Impact Not Overcome by Exercise
JAN 25, 2021
Obesity's Poor Health Impact Not Overcome by Exercise
While there has been limited evidence that activity and fitness can counter the health impacts of excess body fat, a new ...
JAN 26, 2021
Genetics & Genomics
Why Only Some People With a Rare Mutation Get a Heart Condition
JAN 26, 2021
Why Only Some People With a Rare Mutation Get a Heart Condition
Scientists have found a way to explain why a heart condition called hypertrophic cardiomyopathy (HCM) can be so differen ...
Loading Comments...